Search

Your search keyword '"Murphy, E. L."' showing total 33 results

Search Constraints

Start Over You searched for: Author "Murphy, E. L." Remove constraint Author: "Murphy, E. L." Topic htlv-i infections Remove constraint Topic: htlv-i infections
33 results on '"Murphy, E. L."'

Search Results

1. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.

2. Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safety.

3. Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.

4. Delayed hypersensitivity skin testing to mumps and Candida albicans antigens is normal in middle-aged HTLV-I- and-II-infected U.S. cohorts.

5. Laboratory abnormalities in former blood donors seropositive for human T-lymphotropic virus types 1 and 2: a prospective analysis.

6. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results.

7. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study.

8. Low prevalence of flower cells in U.S.A. blood donors infected with human T-lymphotrophic virus types I and II.

9. Psychological distress in blood donors notified of HTLV-I/II infection. Retrovirus Epidemiology Donor Study.

10. Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French Guiana.

11. Laboratory test differences associated with HTLV-I and HTLV-II infection. Retrovirus Epidemiology Donor Study Investigators.

12. Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.

13. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators.

14. A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica.

15. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.

16. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group.

17. Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) in Jamaica: association with antibodies to envelope glycoprotein (gp46) epitopes.

18. Human T-lymphotropic virus type I seroprevalence among Japanese Americans.

19. Determination of human T lymphotropic virus type by polymerase chain reaction and correlation with risk factors in northern California blood donors.

20. Counseling and medical evaluation of HTLV-I- and HTLV-II-infected patients.

21. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion.

22. Gastrointestinal parasitic infection in healthy Jamaican carriers of HTLV-I.

24. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients.

25. The clinical significance of HTLV-I and HTLV-II infection in the AIDS epidemic.

26. Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection.

27. Determination of a unique and immunodominant epitope of human T cell lymphotropic virus type I.

28. Distinguishing between HTLV-I and HTLV-II by western blot.

29. Human T lymphotropic virus type I antibody patterns: evidence of difference by age and risk group.

30. Sexual transmission of human T-lymphotropic virus type I (HTLV-I).

33. Human T-lymphotropic virus type I seroprevalence among Japanese Americans

Catalog

Books, media, physical & digital resources